These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8386553)
21. Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro. Karp JM; Shoichet MS; Davies JE J Biomed Mater Res A; 2003 Feb; 64(2):388-96. PubMed ID: 12522827 [TBL] [Abstract][Full Text] [Related]
23. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Uchida T; Yagi A; Oda Y; Nakada Y; Goto S Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042 [TBL] [Abstract][Full Text] [Related]
24. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor. Desai KG; Mallery SR; Schwendeman SP Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553 [TBL] [Abstract][Full Text] [Related]
25. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Kim H; Kim HW; Suh H Biomaterials; 2003 Nov; 24(25):4671-9. PubMed ID: 12951010 [TBL] [Abstract][Full Text] [Related]
26. PEG modulated release of etanidazole from implantable PLGA/PDLA discs. Wang F; Lee T; Wang CH Biomaterials; 2002 Sep; 23(17):3555-66. PubMed ID: 12109679 [TBL] [Abstract][Full Text] [Related]
27. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation. Liu HW; Chen CH; Tsai CL; Hsiue GH Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421 [TBL] [Abstract][Full Text] [Related]
28. In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide). Ignatius AA; Claes LE Biomaterials; 1996 Apr; 17(8):831-9. PubMed ID: 8730968 [TBL] [Abstract][Full Text] [Related]
29. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528 [TBL] [Abstract][Full Text] [Related]
30. Effect of poly-hydroxy aliphatic ester polymer type on amoxycillin release from cylindrical compacts. Mollo AR; Corrigan OI Int J Pharm; 2003 Dec; 268(1-2):71-9. PubMed ID: 14643978 [TBL] [Abstract][Full Text] [Related]
31. Growth of various cell types in the presence of lactic and glycolic acids: the adverse effect of glycolic acid released from PLAGA copolymer on keratinocyte proliferation. Garric X; Molès JP; Garreau H; Braud C; Guilhou JJ; Vert M J Biomater Sci Polym Ed; 2002; 13(11):1189-201. PubMed ID: 12518799 [TBL] [Abstract][Full Text] [Related]
32. In vivo-in vitro study of biodegradable methadone delivery systems. Negrin CM; Delgado A; Llabrés M; Evora C Biomaterials; 2001 Mar; 22(6):563-70. PubMed ID: 11219720 [TBL] [Abstract][Full Text] [Related]
33. Hydroxylapatite/poly(L-lactide) composites: an animal study on push-out strengths and interface histology. Verheyen CC; de Wijn JR; van Blitterswijk CA; de Groot K; Rozing PM J Biomed Mater Res; 1993 Apr; 27(4):433-44. PubMed ID: 8385142 [TBL] [Abstract][Full Text] [Related]
34. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy. Mader K; Gallez B; Liu KJ; Swartz HM Biomaterials; 1996 Feb; 17(4):457-61. PubMed ID: 8938242 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid). Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556 [TBL] [Abstract][Full Text] [Related]
36. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Lemoine D; Francois C; Kedzierewicz F; Preat V; Hoffman M; Maincent P Biomaterials; 1996 Nov; 17(22):2191-7. PubMed ID: 8922605 [TBL] [Abstract][Full Text] [Related]
37. Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. Puelacher WC; Mooney D; Langer R; Upton J; Vacanti JP; Vacanti CA Biomaterials; 1994 Aug; 15(10):774-8. PubMed ID: 7986941 [TBL] [Abstract][Full Text] [Related]
38. Why degradable polymers undergo surface erosion or bulk erosion. von Burkersroda F; Schedl L; Göpferich A Biomaterials; 2002 Nov; 23(21):4221-31. PubMed ID: 12194525 [TBL] [Abstract][Full Text] [Related]
39. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Sigurdsson TJ; Nygaard L; Tatakis DN; Fu E; Turek TJ; Jin L; Wozney JM; Wikesjö UM Int J Periodontics Restorative Dent; 1996 Dec; 16(6):524-37. PubMed ID: 9242091 [TBL] [Abstract][Full Text] [Related]
40. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size. Shiga K; Muramatsu N; Kondo T J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]